171 related articles for article (PubMed ID: 30722957)
1. Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis.
Martinsson A; Li X; Torp-Pedersen C; Zöller B; Andell P; Andreasen C; Gislason G; Køber L; Sundquist K; Smith JG; Andersson C
Int J Cardiol; 2019 Apr; 281():140-145. PubMed ID: 30722957
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
Sehested TSG; Carlson N; Hansen PW; Gerds TA; Charlot MG; Torp-Pedersen C; Køber L; Gislason GH; Hlatky MA; Fosbøl EL
Eur Heart J; 2019 Jun; 40(24):1963-1970. PubMed ID: 30851041
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
[TBL] [Abstract][Full Text] [Related]
4. Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registry.
Schiele F; Puymirat E; Bonello L; Dentan G; Meneveau N; Collet JP; Motreff P; Ravan R; Leclercq F; Ennezat PV; Ferrières J; Berard L; Simon T; Danchin N
Int J Cardiol; 2015; 187():354-60. PubMed ID: 25839641
[TBL] [Abstract][Full Text] [Related]
5. Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis.
Aryal MR; Karmacharya P; Pandit A; Hakim F; Pathak R; Mainali NR; Ukaigwe A; Mahmood M; Badal M; Fortuin FD
Heart Lung Circ; 2015 Feb; 24(2):185-92. PubMed ID: 25240570
[TBL] [Abstract][Full Text] [Related]
6. Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.
Wu VC; Chen SW; Chou AH; Ting PC; Chang CH; Wu M; Hsieh MJ; Wang CY; Chang SH; Lin MS; Hung KC; Hsieh IC; Chu PH; Wu CS; Lin YS
PLoS One; 2019; 14(10):e0223380. PubMed ID: 31581275
[TBL] [Abstract][Full Text] [Related]
7. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Bittl JA; Baber U; Bradley SM; Wijeysundera DN
J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
[TBL] [Abstract][Full Text] [Related]
8. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
[TBL] [Abstract][Full Text] [Related]
10. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
Sindet-Pedersen C; Lamberts M; Staerk L; Nissen Bonde A; Berger JS; Pallisgaard JL; Lock Hansen M; Torp-Pedersen C; Gislason GH; Olesen JB
J Am Coll Cardiol; 2018 Oct; 72(15):1790-1800. PubMed ID: 30286922
[TBL] [Abstract][Full Text] [Related]
11. One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.
Danchin N; Puymirat E; Cayla G; Cottin Y; Coste P; Gilard M; Goldstein P; Braun F; Belle L; Montalescot G; Ferrières J; Schiele F; Simon T;
Circ Cardiovasc Interv; 2018 Sep; 11(9):e007241. PubMed ID: 30354592
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.
Brener SJ; Kirtane AJ; Rinaldi MJ; Stuckey TD; Witzenbichler B; Weisz G; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Brodie BR; Mehran R; McAndrew T; Stone GW
Circ Cardiovasc Interv; 2018 Oct; 11(10):e006853. PubMed ID: 30354629
[TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.
Wang A; Wu A; Wojdyla D; Lopes RD; Newby LK; Newman MF; Smith PK; Alexander JH
Am Heart J; 2018 May; 199():150-155. PubMed ID: 29754654
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
15. Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study.
Green A; Pottegård A; Broe A; Diness TG; Emneus M; Hasvold P; Gislason GH
BMJ Open; 2016 May; 6(5):e010880. PubMed ID: 27173812
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data.
Nabi H; Rørth R; Tajchman DH; Holmvang L; Torp-Pedersen C; Gislason G; Fosbøl EL; Køber L; Sørensen R
Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):14-21. PubMed ID: 31274145
[TBL] [Abstract][Full Text] [Related]
17. Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.
Moalem K; Baber U; Chandrasekhar J; Claessen BE; Sartori S; Aquino M; Dangas G; Iakovou I; Colombo A; Kini A; Gibson M; Krucoff M; Chieffo A; Moliterno D; Witzenbichler B; Pocock S; Mehran R
Clin Res Cardiol; 2019 Jun; 108(6):643-650. PubMed ID: 30607496
[TBL] [Abstract][Full Text] [Related]
18. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
Stefanescu Schmidt AC; Kereiakes DJ; Cutlip DE; Yeh RW; D'Agostino RB; Massaro JM; Hsieh WH; Mauri L;
Circulation; 2017 May; 135(18):1720-1732. PubMed ID: 28228427
[TBL] [Abstract][Full Text] [Related]
19. Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.
Caneiro-Queija B; Abu-Assi E; Raposeiras-Roubín S; Manzano-Fernández S; Flores Blanco P; López-Cuenca Á; Cobas-Paz R; Gómez-Molina M; Rodríguez-Rodríguez JM; Calvo-Iglesias F; Valdés-Chávarri M; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):829-836. PubMed ID: 29656987
[TBL] [Abstract][Full Text] [Related]
20. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
